| http://www.w3.org/ns/prov#value | - Hence, there is a need to develop new pharmaceuticals for the treatment of metastatic prostate cancer, as well as a need to identify new diagnostic markers that can better discriminate between indolent and aggressive variants of prostate cancer.
|
